<?xml version="1.0" encoding="UTF-8"?>
<ref id="B310-pharmaceuticals-14-00381">
 <label>310.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yan</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Liang</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Gu</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Chu</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Ren</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>P.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A Series of Oleanolic Acid Derivatives as Anti-Hepatitis B Virus Agents: Design, Synthesis, and in Vitro and in Vivo Biological Evaluation</article-title>
  <source>Molecules</source>
  <year>2016</year>
  <volume>21</volume>
  <elocation-id>402</elocation-id>
  <pub-id pub-id-type="doi">10.3390/molecules21040402</pub-id>
  <pub-id pub-id-type="pmid">27023498</pub-id>
 </element-citation>
</ref>
